SCHEMBL20122668

SCHEMBL20122668

CC/C=C(\CO)NCc1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.46
CYP2C19 P33261 2/20 0.46
LMNA P02545 1/20 0.46
CYP2D6 P10635 1/20 0.46
ALOX12 P18054 3/20 0.46
HPGD P15428 2/20 0.46
GAA P10253 2/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
ALPL P05186 1/20 0.45
MEN1 O00255 1/20 0.44
POLB P06746 1/20 0.44
MAPT P10636 1/20 0.44
KMT2A Q03164 1/20 0.44
MMP1 P03956 1/20 0.44
MMP2 P08253 1/20 0.44
MMP9 P14780 1/20 0.44
RIPK1 Q13546 1/20 0.44
IDO1 P14902 1/20 0.43
CA12 O43570 2/20 0.43
CA1 P00915 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12500475 0.87 ALOX12 (0.50) ALDH1A1CYP2C19LMNACYP2D6ALOX12
SCHEMBL23033025 0.79 CA12 (0.43) ALDH1A1CYP2C19LMNACYP2D6ALOX12
SCHEMBL28890860 0.74 CYP2C9 (0.53) ALDH1A1CYP2C19LMNACYP2D6GAA
SCHEMBL27406852 0.74 ALOX12 (0.44) ALDH1A1CYP2C19LMNACYP2D6ALOX12
SCHEMBL23836146 0.71 LMNA (0.68) ALDH1A1CYP2C19LMNAALOX12HPGD
SCHEMBL26606759 0.71 CYP2C9 (0.47) ALDH1A1CYP2C19LMNACYP2D6HPGD
SCHEMBL18755879 0.70 CES2 (0.39) MEN1POLBMAPTKMT2AEPHX2
SCHEMBL11743634 0.70 ALDH1A1 (0.67) ALDH1A1CYP2C19LMNACYP2D6SMN1; SMN2
SCHEMBL11743630 0.70 ALDH1A1 (0.67) ALDH1A1CYP2C19LMNACYP2D6SMN1; SMN2
SCHEMBL1416058 0.69 ALDH1A1 (0.61) ALDH1A1CYP2C19LMNACYP2D6GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2968995-B1 INHIBITORS OF LRRK2 KINASE ACTIVITY ELAN PHARMACEUTICALS LLC (US) 2018-05-09 EP disclosed